title: Metabolic effects of propofol in the isolated perfused rat liver.
abstract: Inhibitory effects of the intravenous anaesthetic propofol on mitochondrial energy metabolism have been reported by several authors. Impairment of energy metabolism is usually coupled to reduction in ATP production, which in turn is expected to lead to several alterations in cell metabolism such as stimulation of glycolysis and inhibition of gluconeogenesis. The present work aimed at finding an answer to the question of how propofol affects energy metabolism-linked parameters in the isolated perfused rat liver. In the fed state, propofol increased glycogenolysis (glucose release), glycolysis (lactate and pyruvate production) and oxygen uptake in the range between 10 and 500 microM. In the liver of fasted rats, propofol up to 100 microM increased oxygen uptake but decreased gluconeogenesis from three different substrates: lactate, alanine and glycerol. When lactate was the substrate 50% inhibition occurred at a propofol concentration of 50 microM. Propofol (100 microM) decreased the ATP content of the liver (-33.3%), increased the AMP content (+25%) and decreased the ATP/ADP and ATP/AMP ratios (49 and 45%, respectively). Most effects of propofol are probably due to impairment of oxidative phosphorylation. Particularly, the combined differential action on oxygen uptake (stimulation) and gluconeogenesis (inhibition) is strongly suggestive of an uncoupling action also under the conditions of the intact cell. This effect, in turn, is consistent with the reported high affinity of the cellular hepatic structure, especially membranes, for propofol.
authors.affiliation: Laboratory of Liver Metabolism, University of Maringá, 87020900 Maringá, Brazil.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Acco
authors.forename: Jurandir Fernando
authors.initials: JF
authors.lastname: Comar
authors.forename: Adelar
authors.initials: A
authors.lastname: Bracht
mesh_terms: D000409:Alanine / Q000378:metabolism; D018686:Anesthetics, Intravenous / Q000494:pharmacology*; D000818:Animals; D004734:Energy Metabolism; D005943:Gluconeogenesis; D005990:Glycerol / Q000378:metabolism; D006019:Glycolysis; D066298:In Vitro Techniques; D007262:Infusions, Intravenous; D019344:Lactic Acid / Q000378:metabolism; D008099:Liver / Q000378:metabolism*; D008297:Male; D008930:Mitochondria, Liver / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D010766:Phosphorylation; D015742:Propofol / Q000494:pharmacology*; D019289:Pyruvic Acid / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors
chemical_list: D018686:Anesthetics, Intravenous; D019344:Lactic Acid; D019289:Pyruvic Acid; D000409:Alanine; D005990:Glycerol; D010100:Oxygen; D015742:Propofol